Heart disease continues to be the most common cause of mortality in both men and women. Lipid profiles have been a cornerstone of heart disease prevention. While it is common to use LDL “bad” and HDL “good” cholesterol measurements to determine a patient’s risk for heart disease, this approach only shows the “tip of the iceberg”. Strategies focused on lowering LDL cholesterol have been effective in reducing heart disease risk by approximtaly 30%, across both primary and secondary prevention stuides. However, the 70% of remainng residual risk has not been addressed. This led to a search for more precise markers of risk. A comprehensive approach to risk startification should include newer markers to personalize patient’s risk assessment, and create an opportunity for actionable plan. Learn how the “new” basic lipid profile can help in identifying atherogenic lipid phenotypes (APLs), and the management strategies.
You'll Learn:
This free course is hosted by Rupa Health — the best way to order, track, and get results from 30+ lab companies in one place.
Rupa reduces the time spent ordering labs by 90% and provides customer service for your patients around lab test collections.
